MICHELLE POWELL: Open Payments
NPI 1376832816 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 18 payments from 6 companies in 2025. Trend: 2023 $356 · 2024 $92 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $264 |
| ABBVIE INC. | 2 | $141 |
| Novo Nordisk Inc | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Braeburn Inc. | 1 | $17 |
Products named: Auvelity, VRAYLAR, CAPLYTA, Ozempic, COBENFY, Rybelsus, BRIXADI.
Industry payments across FL — which companies pay providers there.
